Medidata to Present at Citi 2015 Global Technology Conference

Loading...
Loading...
NEW YORK--(BUSINESS WIRE)--

Medidata MDSO, the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Glen de Vries, president, and Rouven Bergmann, chief financial officer, will present at the Citi 2015 Global Technology Conference on Tuesday, September 8, 2015, at 2:45 p.m. ET in New York.

A live audio webcast will be available on the "Investor" section of Medidata's website at http://investor.mdsol.com. Please visit the website at least 15 minutes prior to the event to register, download and install any necessary audio or video software to access the presentation. For those unable to participate in the live webcast, a replay will be archived on the "Investor" section of Medidata's website at http://investor.mdsol.com for a limited period of time following the conference.

About Medidata

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud® brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investor:
Medidata Solutions
Hulus Alpay, 212-419-1025
halpay@mdsol.com
or
Media – Americas & EMEA:
Medidata Solutions
Nicole Pariser, 212-659-1069
npariser@mdsol.com
or
Media – APAC:
Medidata Solutions
Chitose Yamada, +81 3-4588 0895
cyamada@mdsol.com

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...